Barrington Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $25
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $25
ModivCare's Growth Potential and Asset Value Highlighted Amid Financial Restructuring: Buy Rating With $25 Price Target
ModivCare Is Maintained at Outperform by Barrington Research
ModivCare Analyst Ratings
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Raises Target Price to $25
Deutsche Bank Maintains ModivCare(MODV.US) With Hold Rating, Cuts Target Price to $18
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $30
ModivCare (MODV) Receives a Buy From Lake Street
ModivCare Analyst Ratings
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $30
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Raises Target Price to $22
ModivCare's Strategic Financial Management and EBITDA Growth Potential Affirm Outperform Rating
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $30
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $30
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $19
Barrington Research Adjusts ModivCare Price Target to $19 From $35, Maintains Outperform Rating
ModivCare Analyst Ratings
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $50
ModivCare Analyst Ratings
No Data